Scienture Holdings, Inc. (Nasdaq: SCNX) announced a securities purchase agreement with institutional investors.
The agreement involves the purchase of 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds are expected to be approximately $3.9 million.
Offer Details
3,225,000 shares of common stock at $1.20 per share.
Expected Proceeds
Gross proceeds around $3.9 million.
Offering Closure
Expected to close on August 15, 2025.
Placement Agent
Maxim Group LLC is the sole placement agent.
- The offering is part of Scienture's strategy to enhance value for patients and caregivers.
- The company aims to develop and distribute novel specialty products to meet market needs.
The registered direct offering marks a significant step for Scienture Holdings, Inc. in securing funds for its strategic initiatives.